UBS AM’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-48,416
| Closed | -$1.59M | – | 2805 |
|
|
2022
Q2 | $1.59M | Sell |
48,416
-273
| -0.6% | -$8.63K | ﹤0.01% | 1723 |
|
|
2022
Q1 | $1.28M | Buy |
48,689
+338
| +0.7% | +$8.25K | ﹤0.01% | 2014 |
|
|
2021
Q4 | $1.15M | Buy |
48,351
+650
| +1% | +$16K | ﹤0.01% | 2141 |
|
|
2021
Q3 | $1.2M | Buy |
47,701
+6,954
| +17% | +$177K | ﹤0.01% | 2068 |
|
|
2021
Q2 | $1.06M | Sell |
40,747
-1,894
| -4% | -$51.5K | ﹤0.01% | 2179 |
|
|
2021
Q1 | $1.09M | Hold |
42,641
| – | – | ﹤0.01% | 2050 |
|
|
2020
Q4 | $855K | Sell |
42,641
-591
| -1% | -$11.6K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $741K | Buy |
43,232
+5,649
| +15% | +$107K | ﹤0.01% | 1959 |
|
|
2020
Q2 | $820K | Sell |
37,583
-1,022
| -3% | -$23.4K | ﹤0.01% | 1887 |
|
|
2020
Q1 | $893K | Buy |
38,605
+52
| +0.1% | +$1.51K | ﹤0.01% | 1737 |
|
|
2019
Q4 | $1.27M | Buy |
38,553
+21
| +0.1% | +$673 | ﹤0.01% | 1797 |
|
|
2019
Q3 | $1.23M | Buy |
38,532
+6,772
| +21% | +$197K | ﹤0.01% | 1853 |
|
|
2019
Q2 | $816K | Buy |
31,760
+13,569
| +75% | +$346K | ﹤0.01% | 1983 |
|
|
2019
Q1 | $462K | Sell |
18,191
-5,701
| -24% | -$170K | ﹤0.01% | 2137 |
|
|
2018
Q4 | $813K | Buy |
23,892
+9,193
| +63% | +$299K | ﹤0.01% | 1832 |
|
|
2018
Q3 | $524K | Hold |
14,699
| – | – | ﹤0.01% | 2073 |
|
|
2018
Q2 | $507K | Sell |
14,699
-3,241
| -18% | -$114K | ﹤0.01% | 2091 |
|
|
2018
Q1 | $604K | Buy |
17,940
+1,813
| +11% | +$57.4K | ﹤0.01% | 1956 |
|
|
2017
Q4 | $616K | Hold |
16,127
| – | – | ﹤0.01% | 1904 |
|
|
2017
Q3 | $605K | Buy |
16,127
+5,728
| +55% | +$202K | ﹤0.01% | 1881 |
|
|
2017
Q2 | $388K | Hold |
10,399
| – | – | ﹤0.01% | 1946 |
|
|
2017
Q1 | $408K | Hold |
10,399
| – | – | ﹤0.01% | 1928 |
|
|
2016
Q4 | $362K | Sell |
10,399
-8,700
| -46% | -$342K | ﹤0.01% | 1880 |
|
|
2016
Q3 | $750K | Buy |
19,099
+1,500
| +9% | +$59.8K | ﹤0.01% | 1792 |
|
|
2016
Q2 | $665K | Buy |
17,599
+3,500
| +25% | +$117K | ﹤0.01% | 1822 |
|
|
2016
Q1 | $542K | Sell |
14,099
-6,900
| -33% | -$257K | ﹤0.01% | 1884 |
|
|
2015
Q4 | $1.01M | Hold |
20,999
| – | – | ﹤0.01% | 1741 |
|
|
2015
Q3 | $829K | Buy |
20,999
+6,200
| +42% | +$263K | ﹤0.01% | 1798 |
|
|
2015
Q2 | $630K | Buy |
14,799
+2,300
| +18% | +$91.7K | ﹤0.01% | 1932 |
|
|
2015
Q1 | $493K | Buy |
12,499
+700
| +6% | +$25.8K | ﹤0.01% | 1986 |
|
|
2014
Q4 | $425K | Hold |
11,799
| – | – | ﹤0.01% | 2030 |
|
|
2014
Q3 | $348K | Hold |
11,799
| – | – | ﹤0.01% | 2056 |
|
|
2014
Q2 | $297K | Hold |
11,799
| – | – | ﹤0.01% | 2194 |
|
|
2014
Q1 | $304K | Hold |
11,799
| – | – | ﹤0.01% | 2170 |
|
|
2013
Q4 | $265K | Buy |
+11,799
| New | +$228K | ﹤0.01% | 2212 |
|
Other funds holding NTUS
UBS AM's NTUS Position: Q3 2022 in Review
UBS AM sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 48,416 shares — an estimated $1.59M sold.
UBS AM first reported a position in NTUS in Q4 2013 and held it in 35 quarters. The position peaked at $1.59M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- UBS AM reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- UBS AM sold 48,416 Natus Medical Inc shares in Q3 2022, an estimated $1.59M.
- UBS AM first reported a position in Natus Medical Inc in Q4 2013 and held it in 35 quarters.
- UBS AM's Natus Medical Inc position peaked at $1.59M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.